Lubiprostone is a synthetic prostaglandin E1 derivative and chloride channel activator primarily used in the management of chronic idiopathic constipation, as well as irritable bowel syndrome with constipation… Read more
![Chemical structure of (3aR,4R,5R,6aS)-2-oxo-5-((Tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-cyclopenta[b]furan-4-carbaldehyde](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F32233-41-3-3aR4R5R6aS-2-oxo-5-Tetrahydro-2H-pyran-2-yloxyhexahydro-2H-cyclopentabfuran-4-carbaldehyde.png&w=3840&q=75)
![Chemical structure of (3AR,4S,5R,6aS)-4-(Hydroxymethyl)-5-((tetrahydro-2H-pyran-2-yl)oxy)hexahydro-2H-cyclopenta[b]furan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F69222-61-3-3AR4S5R6aS-4-Hydroxymethyl-5-tetrahydro-2H-pyran-2-yloxyhexahydro-2H-cyclopentabfuran-2-one.png&w=3840&q=75)













![Chemical structure of 7-((1S,2R,5R,8S)-2-(1,1-Difluoropentyl)-2,8-dihydroxy-7-oxobicyclo[3.2.1]octan-6-yl)heptanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-1S2R5R8S-2-11-Difluoropentyl-28-dihydroxy-7-oxobicyclo3.2.1octan-6-ylheptanoic-Acid.png&w=3840&q=75)
![Chemical structure of 7-((2R,4aR,5S,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)heptanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1263283-38-0-7-2R4aR5S7aR-2-11-Difluoropentyl-2-hydroxy-6-oxooctahydrocyclopentabpyran-5-ylheptanoic-Acid.png&w=3840&q=75)
![Chemical structure of 7-((2S,4aS,5S,7aS)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)heptanoic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2743427-14-5-7-2S4aS5S7aS-2-11-Difluoropentyl-2-hydroxy-6-oxooctahydrocyclopentabpyran-5-ylheptanoic-Acid.png&w=3840&q=75)
![Chemical structure of 7-(2-(1,1-Difluoropentyl)-2,8-dihydroxy-7-oxobicyclo[3.2.1]octan-6-yl)heptanoic acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-2-11-Difluoropentyl-28-dihydroxy-7-oxobicyclo3.2.1octan-6-ylheptanoic-acid.png&w=3840&q=75)



![Chemical structure of Benzyl (Z)-7-((2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)hept-5-enoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1447733-80-3-Benzyl-Z-7-2R4aR5R7aR-2-11-difluoropentyl-2-hydroxy-6-oxooctahydrocyclopentabpyran-5-ylhept-5-enoate.png&w=3840&q=75)
![Chemical structure of Cyclohexylmethyl 7-((2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[b]pyran-5-yl)heptanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FCyclohexylmethyl-7-2R4aR5R7aR-2-11-difluoropentyl-2-hydroxy-6-oxooctahydrocyclopentabpyran-5-ylheptanoate.png&w=3840&q=75)






![Chemical structure of rel-(3aR,4S,5R,6aS)-5-Hydroxy-4-(hydroxymethyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F54423-47-1-rel-3aR4S5R6aS-5-Hydroxy-4-hydroxymethyl-33a4566a-hexahydrocyclopentabfuran-2-one.png&w=3840&q=75)
Lubiprostone is a synthetic prostaglandin E1 derivative and chloride channel activator primarily used in the management of chronic idiopathic constipation, as well as irritable bowel syndrome with constipation and opioid-induced constipation. To ensure therapeutic efficacy and safety, pharmaceutical laboratories rely on precise reference standards during rigorous analytical testing and quality control procedures. This category provides an essential collection of Lubiprostone-related compounds, including pharmacopeial and non-pharmacopeial impurities, degradation products, and specific diastereomers necessary for accurate impurity profiling. Additionally, the catalogue features stable isotope labelled compounds, such as deuterated Lubiprostone, which serve as critical internal standards for mass spectrometry and bioanalytical method validation. By utilizing these high-quality materials, researchers can effectively identify, quantify, and monitor potential impurities and metabolites throughout the drug development and manufacturing lifecycle, ensuring compliance with strict regulatory standards.